Mucopolysaccharidosis Market Size is Valued at USD 10.79 Billion in 2023, and is Projected to Reach USD 21.39 Billion by 2032, Growing at a CAGR of 7.9% From 2024 to 2032. The Mucopolysaccharidosis (MPS) System Market refers to the healthcare sector that makes a speciality of the diagnosis, treatment, and control of MPS, a collection of uncommon genetic problems characterised by the...